Glial Fibrillary Acidic Protein in the Diagnosis and Prognosis of Malignant Glial Tumors
Bulletin of Experimental Biology and Medicine(2020)
Abstract
Serum levels of glial fibrillar acidic protein (GFAP) were analyzed in 317 patients with primary and metastatic tumors of the brain, 78 patients with neurological diseases, and 66 normal subjects. A significant increase in the basal level of GFAP was typical of patients with glioblastomas in comparison with other groups (patients with astrocytomas, cerebral metastases, benign tumors, non-tumor diseases, and healthy subjects). An association of GFAP levels with unfavorable prognosis of overall survival in patients with glioblastoma was revealed. The data attest to high specificity and sensitivity of GFAP as a biochemical marker of glioblastoma.
MoreTranslated text
Key words
glial fibrillary acidic protein (GFAP),glioblastoma,neurological diseases of the brain,diagnosis,prognosis
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined